Adefovir Dipivoxil
Back to searchMolecule Structure
Scientific Name
Adefovir Dipivoxil
Description of the Drug
Adefovir dipivoxil is a nucleotide analog used to treat chronic hepatitis B.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00718
http://www.drugbank.ca/drugs/DB00718
Brand Name(s)
Adefovir dipivoxil, Hepsera
Company Owner(s)
Apotex Inc, Gilead Sciences Inc, Sigmapharm Laboratories Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA polymerase/reverse transcriptase | SINGLE PROTEIN | INHIBITOR | CHEMBL2362994 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL29729 | |
| PharmGKB | PA10005 | |
| Human Metabolome Database | HMDB0014856 | |
| DrugBank | DB00718 | |
| PubChem: Thomson Pharma | 14908863 | |
| PubChem | 60871 | |
| Mcule | MCULE-6257358029 | |
| Nikkaji | J592.477D | |
| BindingDB | 50248359 | |
| EPA CompTox Dashboard | DTXSID5046487 | |
| DrugCentral | 88 | |
| ChemicalBook | CB6237644 | |
| rxnorm | HEPSERA | ADEFOVIR DIPIVOXIL |
| PubChem: Drugs of the Future | 12014790 | |
| ChEBI | 31175 | |
| ZINC | ZINC000003930376 |
